Nue Life vs Amgen

Side-by-side comparison of AI visibility scores, market position, and capabilities

Amgen leads in AI visibility (88 vs 35)
Nue Life logo

Nue Life

EmergingMental Health Tech

Ketamine Therapy Platform

Telehealth platform for ketamine-assisted therapy for treatment-resistant depression and PTSD; oral ketamine with coaching at home; licensed physician oversight with published outcomes data.

AI VisibilityBeta
Overall Score
D35
Category Rank
#550 of 596
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
40
Perplexity
41
Gemini
34

About

Nue Life is a Miami-based mental health company that provides at-home ketamine-assisted therapy for treatment-resistant depression, anxiety, PTSD, and OCD through a telehealth model. The company pairs oral ketamine with therapeutic coaching and integration support to treat patients who have not responded to traditional antidepressants. Nue Life's model addresses barriers to ketamine therapy — geographic access to ketamine clinics and prohibitive out-of-pocket costs — by delivering treatment at home with telehealth physician oversight and licensed therapist integration support. The platform has treated thousands of patients with documented outcomes data and published case studies. Nue Life operates in the rapidly growing psychedelic-assisted therapy market, which has seen significant clinical validation for ketamine and clinical trial progress for MDMA and psilocybin. Founded in 2020, the company has raised funding to expand access to ketamine therapy while the regulatory environment for psychedelic medicine continues to evolve.

Full profile
Amgen logo

Amgen

LeaderHealthcare Tech

AI Drug Discovery

Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.

AI VisibilityBeta
Overall Score
A88
Category Rank
#3 of 596
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
83
Perplexity
87
Gemini
85

About

Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.

Full profile

AI Visibility Head-to-Head

35
Overall Score
88
#550
Category Rank
#3
78
AI Consensus
78
stable
Trend
stable
40
ChatGPT
83
41
Perplexity
87
34
Gemini
85
37
Claude
90
33
Grok
92

Key Details

Category
Ketamine Therapy Platform
AI Drug Discovery
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Nue Life
Ketamine Therapy Platform
Only Amgen
AI Drug Discovery

Integrations

Amgen is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.